The FDA Recommends Cannabis-Derived Epilepsy Medication For Approval

May 09, 2018

Last month, an advisory panel to the United States Food and Drug Administration (FDA) voted unanimously to recommend the approval of Epidiolex, an epilepsy medication with cannabidiol as the active ingredient.

If the recommendation is accepted – as it most likely will be – Epidiolex will be the first cannabis-based medication to be available (in a regular pharmacy) with a physician’s prescription. It was created by UK company GW Pharmaceuticals, and has been available in Israeli hospitals and pharmacies for years now.

The drug is used to treat two the most rare and severe forms of childhood epilepsy – Dravet syndrome and Lennox-Gastaut syndrome – both of which typically appear before 5 years of age. In the United States alone, there are nearly 300,000 people, (mostly children) living either of these conditions.

Due to the intensity and frequency of seizure related to these specific disorders, patients have an elevated risk of developmental delays, intellectual and/or physical disabilities, and even death. Finding a safe and effective long term solution for these children is of utmost importance. At the moment, there is no standardized treatment available, but hopefully Epidiolex will change that.

“This is a very good development, and it basically underscores that there are medicinal properties to some of the cannabinoids,” said Dr. Igor Grant, director of the Center for Medicinal Cannabis Research at the University of California San Diego. “I think there could well be other cannabinoids that are of therapeutic use, but there is just not enough research on them to say.”

This isn’t the first “cannabis-derived” prescription medication available on the market, but it is the only one that uses the original, plant-based extract. There are already synthetic CBD treatments available to provide relief to cancer and HIV/AIDS patients suffering with nausea and weight loss.

[Image Credit: Pixabay]

The post The FDA Recommends Cannabis-Derived Epilepsy Medication For Approval appeared first on Cannadelics.

Also in Education

Double Standards: Will Biden Keep His Cannabis Reform Promises?

August 11, 2022

Regardless of what side of the political fence you’re on, there is one thing everyone can agree on: Republicans are more conservative, and Democrats are more liberal – especially when it comes to progressive drug policies. And while this statement rings true almost 100% of the time, the exact opposite applies to our current president, […]

The post Double Standards: Will Biden Keep His Cannabis Reform Promises? appeared first on Cannadelics.

Continue Reading

Cannabis May Be “Useful Treatment Strategy” for Fibromyalgia Patients

August 11, 2022


Cannabis May Be “Useful Treatment Strategy” for Fibromyalgia Patients by Frank Schuler

Fibromyalgia is a serious problem across the globe, affecting people of all ages. It is estimated that as many as one out of every twenty people on earth suffer from the condition to some degree. According to Mayo Clinic, “Fibromyalgia is a disorder characterized by widespread musculoskeletal pain accompanied by fatigue, sleep, memory and mood issues.” Unfortunately, there is […]

A link to your site, with your site's name and description as anchor text.

Continue Reading

The great serotonin myth – what really causes depression?

August 11, 2022

In recent weeks, chaos has ensued in the scientific Twittersphere. A new study has brought a debate that has long been had behind the scenes to centre stage – and…

Continue Reading